These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27086281)

  • 1. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
    Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
    Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
    Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
    Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
    Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
    J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.
    Hu XQ; Lovinger DM
    Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational Changes in the 5-HT
    Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
    Newman AS; Batis N; Grafton G; Caputo F; Brady CA; Lambert JJ; Peters JA; Gordon J; Brain KL; Powell AD; Barnes NM
    Br J Pharmacol; 2013 Jul; 169(6):1228-38. PubMed ID: 23594147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
    Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM
    Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
    Thompson AJ; Lummis SC
    Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
    Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
    Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthosteric and Allosteric Activation of Human 5-HT
    Rodriguez Araujo N; Fabiani C; Mazzarini Dimarco A; Bouzat C; Corradi J
    Biophys J; 2020 Oct; 119(8):1670-1682. PubMed ID: 32946769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of M2-M3 loop in governing properties of genistein at the α7 nicotinic acetylcholine receptor inferred from α7/5-HT3A chimera.
    Grønlien JH; Ween H; Thorin-Hagene K; Cassar S; Li J; Briggs CA; Gopalakrishnan M; Malysz J
    Eur J Pharmacol; 2010 Nov; 647(1-3):37-47. PubMed ID: 20816816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.
    Pandhare A; Pappu AS; Wilms H; Blanton MP; Jansen M
    Neuropharmacology; 2017 Feb; 113(Pt A):89-99. PubMed ID: 27671323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a 5-HT
    Price KL; Lummis SCR
    ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
    Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
    Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
    Hu XQ; Lovinger DM
    J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
    Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
    Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
    Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
    J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR 57227A is a partial agonist/partial antagonist of 5-HT
    Nakamura Y; Kondo M; Koyama Y; Shimada S
    Biochem Biophys Res Commun; 2019 Jan; 508(2):590-596. PubMed ID: 30509492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtle Differences among 5-HT
    Price KL; Hirayama Y; Lummis SCR
    ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.